IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $25,000 | -34.2% | 2,283 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $38,000 | -33.3% | 2,283 | -23.2% | 0.00% | -33.3% |
| Q4 2021 | $57,000 | -27.8% | 2,971 | -6.7% | 0.00% | -40.0% |
| Q3 2021 | $79,000 | -6.0% | 3,183 | -1.9% | 0.01% | 0.0% |
| Q2 2021 | $84,000 | -57.8% | 3,246 | -48.4% | 0.01% | -64.3% |
| Q1 2021 | $199,000 | -64.2% | 6,285 | -47.5% | 0.01% | -68.9% |
| Q4 2020 | $556,000 | +42.6% | 11,980 | +1.2% | 0.04% | +36.4% |
| Q3 2020 | $390,000 | +25.0% | 11,840 | +4.0% | 0.03% | +32.0% |
| Q2 2020 | $312,000 | +169.0% | 11,390 | +193.6% | 0.02% | +127.3% |
| Q1 2020 | $116,000 | +1350.0% | 3,880 | +385.0% | 0.01% | +1000.0% |
| Q1 2019 | $8,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |